(Q53556372)

15 May 2018

title

Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction. (English)

1 reference

15 May 2018

0 references

Philbin EF

1

1 reference

15 May 2018

Santella RN

series ordinal

2

1 reference

15 May 2018

Rocco TA Jr

series ordinal

3

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 March 1999

1 reference

15 May 2018

Journal of the American Geriatrics Society

published in

1 reference

15 May 2018

volume

47

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

302-308

1 reference

15 May 2018

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Perspective of the pharmaceutical industry on the development of new drugs for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Does QI work? The Management to Improve Survival in Congestive Heart Failure (MISCHF) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Acute heart failure: determinants of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

The angiographic incidence of renal artery stenosis in the arteriosclerotic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1999.TB02993.X

10.1111/J.1532-5415.1999.TB02993.X

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018